Cardiorenal actions of TRV120027, a novel ß-arrestin-biased ligand at the angiotensin II type i receptor, in healthy and heart failure canines: A novel therapeutic strategy for acute heart failure
Guido Boerrigter, Michael W. Lark, Erin J. Whalen, David G. Soergel, Jonathan D. Violin, John C. Burnett
Dive into the research topics of 'Cardiorenal actions of TRV120027, a novel ß-arrestin-biased ligand at the angiotensin II type i receptor, in healthy and heart failure canines: A novel therapeutic strategy for acute heart failure'. Together they form a unique fingerprint.